Cargando…

TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection

BACKGROUND & AIMS: HDV infection induces the most severe form of human viral hepatitis. However, the specific reasons for the severity of the disease remain unknown. Recently, we developed an HDV replication mouse model in which, for the first time, liver damage was detected. METHODS: HDV and HB...

Descripción completa

Detalles Bibliográficos
Autores principales: Usai, Carla, Maestro, Sheila, Camps, Gracian, Olague, Cristina, Suárez-Amaran, Lester, Vales, Africa, Aragon, Tomas, Hommel, Mirja, Aldabe, Rafael, Gonzalez-Aseguinolaza, Gloria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200939/
https://www.ncbi.nlm.nih.gov/pubmed/32382723
http://dx.doi.org/10.1016/j.jhepr.2020.100098
_version_ 1783529441968783360
author Usai, Carla
Maestro, Sheila
Camps, Gracian
Olague, Cristina
Suárez-Amaran, Lester
Vales, Africa
Aragon, Tomas
Hommel, Mirja
Aldabe, Rafael
Gonzalez-Aseguinolaza, Gloria
author_facet Usai, Carla
Maestro, Sheila
Camps, Gracian
Olague, Cristina
Suárez-Amaran, Lester
Vales, Africa
Aragon, Tomas
Hommel, Mirja
Aldabe, Rafael
Gonzalez-Aseguinolaza, Gloria
author_sort Usai, Carla
collection PubMed
description BACKGROUND & AIMS: HDV infection induces the most severe form of human viral hepatitis. However, the specific reasons for the severity of the disease remain unknown. Recently, we developed an HDV replication mouse model in which, for the first time, liver damage was detected. METHODS: HDV and HBV replication-competent genomes and HDV antigens were delivered to mouse hepatocytes using adeno-associated vectors (AAVs). Aminotransferase elevation, liver histopathology, and hepatocyte death were evaluated and the immune infiltrate was characterized. Liver transcriptomic analysis was performed. Mice deficient for different cellular and molecular components of the immune system, as well as depletion and inhibition studies, were employed to elucidate the causes of HDV-mediated liver damage. RESULTS: AAV-mediated HBV/HDV coinfection caused hepatocyte necrosis and apoptosis. Activated T lymphocytes, natural killer cells, and proinflammatory macrophages accounted for the majority of the inflammatory infiltrate. However, depletion studies and the use of different knockout mice indicated that neither T cells, natural killer cells nor macrophages were necessary for HDV-induced liver damage. Transcriptomic analysis revealed a strong activation of type I and II interferon (IFN) and tumor necrosis factor (TNF)-α pathways in HBV/HDV-coinfected mice. While the absence of IFN signaling had no effect, the use of a TNF-α antagonist resulted in a significant reduction of HDV-associated liver injury. Furthermore, hepatic expression of HDAg resulted in the induction of severe liver damage, which was T cell- and TNF-α-independent. CONCLUSIONS: Both host (TNF-α) and viral (HDV antigens) factors play a relevant role in HDV-induced liver damage. Importantly, pharmacological inhibition of TNF-α may offer an attractive strategy to aid control of HDV-induced acute liver damage. LAY SUMMARY: Chronic hepatitis delta constitutes the most severe form of viral hepatitis. There is limited data on the mechanism involved in hepatitis delta virus (HDV)-induced liver pathology. Our data indicate that a cytokine (TNF-α) and HDV antigens play a relevant role in HDV-induced liver damage.
format Online
Article
Text
id pubmed-7200939
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-72009392020-05-07 TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection Usai, Carla Maestro, Sheila Camps, Gracian Olague, Cristina Suárez-Amaran, Lester Vales, Africa Aragon, Tomas Hommel, Mirja Aldabe, Rafael Gonzalez-Aseguinolaza, Gloria JHEP Rep Research Article BACKGROUND & AIMS: HDV infection induces the most severe form of human viral hepatitis. However, the specific reasons for the severity of the disease remain unknown. Recently, we developed an HDV replication mouse model in which, for the first time, liver damage was detected. METHODS: HDV and HBV replication-competent genomes and HDV antigens were delivered to mouse hepatocytes using adeno-associated vectors (AAVs). Aminotransferase elevation, liver histopathology, and hepatocyte death were evaluated and the immune infiltrate was characterized. Liver transcriptomic analysis was performed. Mice deficient for different cellular and molecular components of the immune system, as well as depletion and inhibition studies, were employed to elucidate the causes of HDV-mediated liver damage. RESULTS: AAV-mediated HBV/HDV coinfection caused hepatocyte necrosis and apoptosis. Activated T lymphocytes, natural killer cells, and proinflammatory macrophages accounted for the majority of the inflammatory infiltrate. However, depletion studies and the use of different knockout mice indicated that neither T cells, natural killer cells nor macrophages were necessary for HDV-induced liver damage. Transcriptomic analysis revealed a strong activation of type I and II interferon (IFN) and tumor necrosis factor (TNF)-α pathways in HBV/HDV-coinfected mice. While the absence of IFN signaling had no effect, the use of a TNF-α antagonist resulted in a significant reduction of HDV-associated liver injury. Furthermore, hepatic expression of HDAg resulted in the induction of severe liver damage, which was T cell- and TNF-α-independent. CONCLUSIONS: Both host (TNF-α) and viral (HDV antigens) factors play a relevant role in HDV-induced liver damage. Importantly, pharmacological inhibition of TNF-α may offer an attractive strategy to aid control of HDV-induced acute liver damage. LAY SUMMARY: Chronic hepatitis delta constitutes the most severe form of viral hepatitis. There is limited data on the mechanism involved in hepatitis delta virus (HDV)-induced liver pathology. Our data indicate that a cytokine (TNF-α) and HDV antigens play a relevant role in HDV-induced liver damage. Elsevier 2020-03-10 /pmc/articles/PMC7200939/ /pubmed/32382723 http://dx.doi.org/10.1016/j.jhepr.2020.100098 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Usai, Carla
Maestro, Sheila
Camps, Gracian
Olague, Cristina
Suárez-Amaran, Lester
Vales, Africa
Aragon, Tomas
Hommel, Mirja
Aldabe, Rafael
Gonzalez-Aseguinolaza, Gloria
TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection
title TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection
title_full TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection
title_fullStr TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection
title_full_unstemmed TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection
title_short TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection
title_sort tnf-alpha inhibition ameliorates hdv-induced liver damage in a mouse model of acute severe infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200939/
https://www.ncbi.nlm.nih.gov/pubmed/32382723
http://dx.doi.org/10.1016/j.jhepr.2020.100098
work_keys_str_mv AT usaicarla tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection
AT maestrosheila tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection
AT campsgracian tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection
AT olaguecristina tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection
AT suarezamaranlester tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection
AT valesafrica tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection
AT aragontomas tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection
AT hommelmirja tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection
AT aldaberafael tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection
AT gonzalezaseguinolazagloria tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection